These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 13851958)

  • 1. [PAS concentration in the pulmonary tuberculosis lesion. Part I. Punctual movement of PAS-Na concentration intravenously injected. I].
    HASHIMOTO T
    Kekkaku; 1959 Dec; 34():870-5. PubMed ID: 13851958
    [No Abstract]   [Full Text] [Related]  

  • 2. [PAS concentration in the pulmonary tuberculosis lesion. Part II. Periodical change of PAS-Na concentration intravenously injected. II].
    HASHIMOTO T
    Kekkaku; 1960 Jan; 35():24-8. PubMed ID: 13851959
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of chemotherapy in pulmonary tuberculosis. High doses of isoniazid and PAS versus daily streptomycin with high doses of isoniazid and PAS.
    BERTE SJ; BOWEN CD
    Am Rev Respir Dis; 1960 Mar; 81():407-11. PubMed ID: 13799949
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kanamycin in association with PAS-perfusion in the treatment of pulmonary tuberculosis].
    TODOROFF T
    Minerva Med; 1960 Sep; 51():3129-33. PubMed ID: 13777166
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of tuberculosis with PAS-streptomycin pantothenate in venous perfusion].
    KUNTZ E
    G Ital Tuberc Mal Torace; 1959; 13():343-52. PubMed ID: 14412780
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of clinical study of the therapy of tuberculosis with intravenous PAS-streptomycin-pantothenate infusions and their combination possibilities].
    KUNTZ E
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1959; 121():269-92. PubMed ID: 14412779
    [No Abstract]   [Full Text] [Related]  

  • 7. The prevalence of bacterial resistance to isoniazid and to PAS in patients with acute pulmonary tuberculosis presenting for treatment in East Africa.
    PEPYS J; MITCHISON DA; KINSLEY BJ
    Tubercle; 1960 Feb; 41():32-6. PubMed ID: 14431677
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of isoniazid alone with isoniazid--PAS in the original chemotherapy of noncavitary pulmonary tuberculosis. Results from the Veterans Administration-Armed Forces co-operative study on the chemotherapy of tuberculosis.
    PHILLIPS S
    Am Rev Respir Dis; 1959 Nov; 80():641-7. PubMed ID: 14432637
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug resistance in out-patients treated with sodium PAS and isoniazid cachets.
    SIMPSON JM
    Tubercle; 1959 Dec; 40():453-6. PubMed ID: 14447015
    [No Abstract]   [Full Text] [Related]  

  • 10. [Potassium p-aminosalicylate in the treatment of pulmonary tuberculosis].
    REBORA F; VALENCIA H
    Gac Med Mex; 1959 Oct; 89():841-50. PubMed ID: 14436749
    [No Abstract]   [Full Text] [Related]  

  • 11. PARA-AMINOSALICYLIC acid (PAS) and streptomycin in pulmonary tuberculosis; comparison between 84 PAS-treated and 82 streptomycin-treated cases.
    Acta Tuberc Scand; 1952; 27(3-5):157-75. PubMed ID: 13040105
    [No Abstract]   [Full Text] [Related]  

  • 12. Usefulness of a combined isoniazid, para-aminosalicylic acid and pyridoxine preparation.
    MANDEL W
    Am Pract Dig Treat; 1959 Oct; 10():1737-9. PubMed ID: 14420557
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment in pulmonary tuberculosis with subcutaneous (Para-Aminosalicylic Acid) PAS infusisons].
    Berger G; Kirschner H
    Tuberkulosearzt; 1956 Mar; 10(3):154-60. PubMed ID: 13324973
    [No Abstract]   [Full Text] [Related]  

  • 14. [Perfusions with solutions of para-aminosalicylic acid (PAS) in the treatment of pulmonary tuberculosis].
    PARAF J; ZIVY P; DESBORDES J; BORY I; PARAF
    Bull Acad Natl Med; 1951 Nov-Dec 4; 135(35-36):622-4. PubMed ID: 14925494
    [No Abstract]   [Full Text] [Related]  

  • 15. Para-aminosalicylic acid (PAS) in cavernous pulmonary tuberculosis; oral treatment; comparison between the effects of PAS in oral and transthoracic administration.
    DIFS H
    Acta Tuberc Scand; 1951; 25(2-3):128-63. PubMed ID: 14810565
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the metabolism of PAS. III. With special reference to the relation between the PAS-Ca concentration in the blood and PAS glycosuria].
    TAKAHASHI H
    Yokohama Med Bull; 1961 Aug; 12():146-50. PubMed ID: 13919041
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of mycobacterial resistance to PAS in pulmonary tuberculosis.
    WINBLAD S; JEPPSSON E; SELANDER E
    Acta Tuberc Scand; 1959; 37():187-94. PubMed ID: 13845173
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of working conditions on chemotherapy of pulmonary tuberculosis].
    YASHIRO A
    Nihon Eiseigaku Zasshi; 1961 Jun; 16():105-10. PubMed ID: 13787252
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is resistance break-through possible after INH and PAS long-term therapy in pulmonary tuberculosis by the use of INHA-PAS?].
    DEBERTSHAUSER E
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1961; 124():450-5. PubMed ID: 13884647
    [No Abstract]   [Full Text] [Related]  

  • 20. [PAS concentration in the blood in pulmonary tuberculosis treated by PAS; comparison with radioclinical results].
    VERAN P; LASAUSSE
    Paris Med; 1950 Oct; 40(39):546-7. PubMed ID: 14797292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.